Nonoperating Income (Expense) of NKGen Biotech, Inc. from 30 Jun 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NKGen Biotech, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Jun 2021 to 31 Mar 2025.
  • NKGen Biotech, Inc. Nonoperating Income (Expense) for the quarter ending 31 Mar 2025 was $20,016,000, a 794% increase year-over-year.
  • NKGen Biotech, Inc. annual Nonoperating Income (Expense) for 2024 was $17,267,000, a 68% increase from 2023.
  • NKGen Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $53,201,000, a 789% decline from 2022.
  • NKGen Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $7,726,755, a 409% increase from 2021.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

NKGen Biotech, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $20,016,000 +$17,777,000 +794% 01 Jan 2025 31 Mar 2025 10-Q 20 Jan 2026 2025 Q1
Q1 2024 $2,239,000 +$501,287 +29% 01 Jan 2024 31 Mar 2024 10-Q 20 Jan 2026 2025 Q1
Q2 2023 $5,951,788 $1,132,307 -$777,382 -41% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $6,729,170 $1,737,713 -$997,585 -36% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $7,726,755 $1,610,669 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2023 2022 FY
Q3 2022 $1,471,099 -$4,027,162 -73% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,909,689 +$5,957,330 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $2,735,298 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $5,498,261 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $4,047,641 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2

NKGen Biotech, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $17,267,000 +$35,934,000 +68% 01 Jan 2024 31 Dec 2024 10-K 08 Oct 2025 2024 FY
2023 $53,201,000 -$60,927,755 -789% 01 Jan 2023 31 Dec 2023 10-K 08 Oct 2025 2024 FY
2022 $7,726,755 +$6,209,186 +409% 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2023 2022 FY
2021 $1,517,569 28 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.